Nalu Medical, Inc., headquartered in the United States, is a pioneering company in the medical device industry, specialising in innovative solutions for chronic pain management. Founded in 2015, Nalu has quickly established itself as a leader in neuromodulation technology, particularly with its unique, miniaturised implantable devices designed for spinal cord stimulation. The company’s flagship product, the Nalu Neurostimulation System, stands out due to its compact size and rechargeable capabilities, offering patients a more convenient and effective treatment option. With a commitment to advancing patient care, Nalu Medical has achieved significant milestones, including regulatory approvals and successful clinical outcomes, solidifying its position in the competitive landscape of pain management solutions.
How does Nalu Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Nalu Medical, Inc.'s score of 18 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nalu Medical, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Nalu Medical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the company operates within the medical technology sector, it may face increasing pressure to adopt sustainable practices and transparency in emissions reporting in line with industry trends.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Nalu Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
